abstract |
The present invention relates to novel tetrahydrobenzo [d] azepin-2-one derivatives, processes for their preparation, their use for the treatment and / or prevention of diseases and diseases, preferably cardiovascular diseases, in particular dyslipidemia And its use for the manufacture of a medicament for treating and / or preventing arteriosclerosis, restenosis and ischemia. [Chemical 1] |